First-in-human Study of VE303 in Healthy Adult Volunteers

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

This study was designed to evaluate safety and tolerability of a range of doses of VE303 in healthy adult volunteers. The study also evaluated pharmacokinetics of intestinal colonization by the VE303 strains and pharmacodynamics of recovery of the gut microbiota after administration of antibiotics followed by a course of VE303.

Key facts

Study ID

NCT04236778

Run by

Vedanta Biosciences, Inc.

People needed

39

Starts

2017-11-28

Expected to finish

2019-03-11

Last updated by the study team

2020-01-27

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

Where it is running

• Pharmaron CPC — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.